The University of Chicago Header Logo

Connection

James Liao to Animals

This is a "connection" page, showing publications James Liao has written about Animals.
Connection Strength

2.095
  1. Emerging views of statin pleiotropy and cholesterol lowering. Cardiovasc Res. 2022 01 29; 118(2):413-423.
    View in: PubMed
    Score: 0.052
  2. Vascular Stiffening Mediated by Rho-Associated Coiled-Coil Containing Kinase Isoforms. J Am Heart Assoc. 2021 10 19; 10(20):e022568.
    View in: PubMed
    Score: 0.051
  3. Regulator of G-Protein Signaling 5 Maintains Brain Endothelial Cell Function in Focal Cerebral Ischemia. J Am Heart Assoc. 2020 09 15; 9(18):e017533.
    View in: PubMed
    Score: 0.048
  4. Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening. Expert Opin Ther Targets. 2020 01; 24(1):47-62.
    View in: PubMed
    Score: 0.046
  5. The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. Curr Vasc Pharmacol. 2019; 17(3):222-232.
    View in: PubMed
    Score: 0.042
  6. Neuroprotection Mediated by Upregulation of Endothelial Nitric Oxide Synthase in Rho-Associated, Coiled-Coil-Containing Kinase 2 Deficient Mice. Circ J. 2018 03 23; 82(4):1195-1204.
    View in: PubMed
    Score: 0.040
  7. Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res. 2017 Jan 06; 120(1):229-243.
    View in: PubMed
    Score: 0.037
  8. Rho Kinases and Cardiac Remodeling. Circ J. 2016 Jun 24; 80(7):1491-8.
    View in: PubMed
    Score: 0.035
  9. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol Rev. 2015; 67(1):103-17.
    View in: PubMed
    Score: 0.032
  10. Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother. 2014 Feb; 14(2):173-85.
    View in: PubMed
    Score: 0.030
  11. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Antioxid Redox Signal. 2014 Mar 10; 20(8):1251-67.
    View in: PubMed
    Score: 0.029
  12. Linking endothelial dysfunction with endothelial cell activation. J Clin Invest. 2013 Feb; 123(2):540-1.
    View in: PubMed
    Score: 0.028
  13. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2. FASEB J. 2013 Apr; 27(4):1439-49.
    View in: PubMed
    Score: 0.028
  14. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury. Vasc Med. 2012 Dec; 17(6):379-85.
    View in: PubMed
    Score: 0.027
  15. ROCKs as immunomodulators of stroke. Expert Opin Ther Targets. 2012 Oct; 16(10):1013-25.
    View in: PubMed
    Score: 0.027
  16. A mouse model of diet-induced obesity and insulin resistance. Methods Mol Biol. 2012; 821:421-33.
    View in: PubMed
    Score: 0.026
  17. Mitohormesis: another pleiotropic effect of statins? Eur Heart J. 2012 Jun; 33(11):1299-301.
    View in: PubMed
    Score: 0.026
  18. Role of Rho kinase isoforms in murine allergic airway responses. Eur Respir J. 2011 Oct; 38(4):841-50.
    View in: PubMed
    Score: 0.025
  19. Notch1 in bone marrow-derived cells mediates cardiac repair after myocardial infarction. Circulation. 2011 Mar 01; 123(8):866-76.
    View in: PubMed
    Score: 0.025
  20. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci. 2011 Mar; 32(3):167-73.
    View in: PubMed
    Score: 0.024
  21. NF-?B and innate immunity in ischemic stroke. Ann N Y Acad Sci. 2010 Oct; 1207:32-40.
    View in: PubMed
    Score: 0.024
  22. Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction. Trends Cardiovasc Med. 2010 Oct; 20(7):228-31.
    View in: PubMed
    Score: 0.024
  23. Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr Opin Pharmacol. 2010 Apr; 10(2):116-21.
    View in: PubMed
    Score: 0.023
  24. Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection. Expert Rev Neurother. 2009 Aug; 9(8):1171-86.
    View in: PubMed
    Score: 0.022
  25. Smooth muscle Notch1 mediates neointimal formation after vascular injury. Circulation. 2009 May 26; 119(20):2686-92.
    View in: PubMed
    Score: 0.022
  26. Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Sci Signal. 2009 Mar 17; 2(62):ra11.
    View in: PubMed
    Score: 0.022
  27. Rac1 is a critical mediator of endothelium-derived neurotrophic activity. Sci Signal. 2009 Mar 10; 2(61):ra10.
    View in: PubMed
    Score: 0.021
  28. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des. 2009; 15(5):467-78.
    View in: PubMed
    Score: 0.021
  29. Rho kinase: an important mediator of atherosclerosis and vascular disease. Curr Pharm Des. 2009; 15(27):3108-15.
    View in: PubMed
    Score: 0.021
  30. Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation. 2008 Nov 18; 118(21):2166-73.
    View in: PubMed
    Score: 0.021
  31. Fine-tuning the angiogenic response to vascular endothelial growth factor. Circ Res. 2008 Aug 01; 103(3):229-30.
    View in: PubMed
    Score: 0.021
  32. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res. 2008 Aug 15; 103(4):360-8.
    View in: PubMed
    Score: 0.020
  33. ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J Clin Invest. 2008 May; 118(5):1632-44.
    View in: PubMed
    Score: 0.020
  34. Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection. J Cereb Blood Flow Metab. 2008 Jul; 28(7):1285-93.
    View in: PubMed
    Score: 0.020
  35. Dynamic regulation of endothelial NOS mediated by competitive interaction with alpha-actinin-4 and calmodulin. FASEB J. 2008 May; 22(5):1450-7.
    View in: PubMed
    Score: 0.020
  36. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):s39-42.
    View in: PubMed
    Score: 0.020
  37. A method for measuring Rho kinase activity in tissues and cells. Methods Enzymol. 2008; 439:181-9.
    View in: PubMed
    Score: 0.020
  38. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase? Curr Atheroscler Rep. 2007 Nov; 9(5):384-8.
    View in: PubMed
    Score: 0.020
  39. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 2007 Jul; 50(1):17-24.
    View in: PubMed
    Score: 0.019
  40. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation. 2007 Jun 26; 115(25):3197-204.
    View in: PubMed
    Score: 0.019
  41. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. Am J Physiol Heart Circ Physiol. 2007 Apr; 292(4):H1937-42.
    View in: PubMed
    Score: 0.018
  42. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res. 2007 Jan 05; 100(1):70-8.
    View in: PubMed
    Score: 0.018
  43. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A. 2006 Sep 19; 103(38):14104-9.
    View in: PubMed
    Score: 0.018
  44. Rho-kinase: a potential link between hypercholesterolemia and abnormal vascular smooth muscle contraction. Circ Res. 2006 Aug 04; 99(3):238-9.
    View in: PubMed
    Score: 0.018
  45. FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1. Circ Res. 2006 Sep 01; 99(5):468-76.
    View in: PubMed
    Score: 0.018
  46. Requirement of Rac1 in the development of cardiac hypertrophy. Proc Natl Acad Sci U S A. 2006 May 09; 103(19):7432-7.
    View in: PubMed
    Score: 0.018
  47. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway. Circ Res. 2006 May 12; 98(9):1134-40.
    View in: PubMed
    Score: 0.018
  48. Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol. 2006 Mar; 290(3):C661-8.
    View in: PubMed
    Score: 0.017
  49. Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest. 2006 Feb; 116(2):334-43.
    View in: PubMed
    Score: 0.017
  50. Rho GTPases, statins, and nitric oxide. Circ Res. 2005 Dec 09; 97(12):1232-5.
    View in: PubMed
    Score: 0.017
  51. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation. 2005 Nov 08; 112(19):2959-65.
    View in: PubMed
    Score: 0.017
  52. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke. 2005 Oct; 36(10):2251-7.
    View in: PubMed
    Score: 0.017
  53. Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation. 2005 Jun 21; 111(24):3261-8.
    View in: PubMed
    Score: 0.017
  54. Essential role of endothelial Notch1 in angiogenesis. Circulation. 2005 Apr 12; 111(14):1826-32.
    View in: PubMed
    Score: 0.016
  55. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005; 45:89-118.
    View in: PubMed
    Score: 0.016
  56. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004 Oct; 24(10):1842-7.
    View in: PubMed
    Score: 0.016
  57. Statins and myocardial hypertrophy. Coron Artery Dis. 2004 Aug; 15(5):247-50.
    View in: PubMed
    Score: 0.016
  58. Statin therapy: having the good without the bad. Hypertension. 2004 Jun; 43(6):1171-2.
    View in: PubMed
    Score: 0.015
  59. Inhibition of MHC II gene transcription by nitric oxide and antioxidants. Curr Pharm Des. 2004; 10(8):893-8.
    View in: PubMed
    Score: 0.015
  60. 11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression. Bioorg Med Chem Lett. 2003 Nov 17; 13(22):4011-4.
    View in: PubMed
    Score: 0.015
  61. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol. 2003 Aug; 23(16):5726-37.
    View in: PubMed
    Score: 0.015
  62. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol. 2003 Jul; 35(7):851-9.
    View in: PubMed
    Score: 0.014
  63. Cross-coupling between the oestrogen receptor and phosphoinositide 3-kinase. Biochem Soc Trans. 2003 Feb; 31(Pt 1):66-70.
    View in: PubMed
    Score: 0.014
  64. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler Thromb Vasc Biol. 2003 Feb 01; 23(2):198-203.
    View in: PubMed
    Score: 0.014
  65. Nonnuclear actions of estrogen. Arterioscler Thromb Vasc Biol. 2002 Dec 01; 22(12):1952-61.
    View in: PubMed
    Score: 0.014
  66. Beyond lipid lowering: the role of statins in vascular protection. Int J Cardiol. 2002 Nov; 86(1):5-18.
    View in: PubMed
    Score: 0.014
  67. Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel. Proc Natl Acad Sci U S A. 2002 Oct 01; 99(20):13108-13.
    View in: PubMed
    Score: 0.014
  68. 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res. 2002 Jul 12; 91(1):17-24.
    View in: PubMed
    Score: 0.014
  69. Non-nuclear actions of estrogen: new targets for prevention and treatment of cardiovascular disease. Mol Interv. 2002 Jul; 2(4):219-28.
    View in: PubMed
    Score: 0.014
  70. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res. 2002 May 17; 90(9):1020-7.
    View in: PubMed
    Score: 0.013
  71. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med. 2002 May; 8(5):473-9.
    View in: PubMed
    Score: 0.013
  72. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 2001 Nov; 21(11):1712-9.
    View in: PubMed
    Score: 0.013
  73. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest. 2001 Nov; 108(10):1429-37.
    View in: PubMed
    Score: 0.013
  74. Increase in Blood-Brain Barrier (BBB) Permeability Is Regulated by MMP3 via the ERK Signaling Pathway. Oxid Med Cell Longev. 2021; 2021:6655122.
    View in: PubMed
    Score: 0.012
  75. Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem. 2001 May 11; 276(19):15983-9.
    View in: PubMed
    Score: 0.012
  76. Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. Arterioscler Thromb Vasc Biol. 2001 Feb; 21(2):227-32.
    View in: PubMed
    Score: 0.012
  77. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 2000 Sep 28; 407(6803):538-41.
    View in: PubMed
    Score: 0.012
  78. Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis. J Clin Invest. 2020 07 01; 130(7):3654-3670.
    View in: PubMed
    Score: 0.012
  79. A functional role of I kappa B-epsilon in endothelial cell activation. J Immunol. 2000 Mar 15; 164(6):3316-22.
    View in: PubMed
    Score: 0.012
  80. A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease. Transl Stroke Res. 2020 06; 11(3):365-376.
    View in: PubMed
    Score: 0.011
  81. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999 Aug 20; 285(5431):1276-9.
    View in: PubMed
    Score: 0.011
  82. Activation of guanine nucleotide-binding proteins and induction of endothelial tissue-type plasminogen activator gene transcription by alcohol. J Biol Chem. 1999 Apr 23; 274(17):12055-60.
    View in: PubMed
    Score: 0.011
  83. Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease. Stroke. 2019 03; 50(3):738-744.
    View in: PubMed
    Score: 0.011
  84. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol. 1998 Aug 15; 161(4):1970-6.
    View in: PubMed
    Score: 0.010
  85. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8880-5.
    View in: PubMed
    Score: 0.010
  86. Impaired Cognitive Performance in Endothelial Nitric Oxide Synthase Knockout Mice After Ischemic Stroke: A Pilot Study. Am J Phys Med Rehabil. 2018 07; 97(7):492-499.
    View in: PubMed
    Score: 0.010
  87. The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2018 04; 58(4):471-481.
    View in: PubMed
    Score: 0.010
  88. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998 Mar 31; 97(12):1129-35.
    View in: PubMed
    Score: 0.010
  89. Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets. Cardiovasc Res. 2017 Sep 01; 113(11):1307-1317.
    View in: PubMed
    Score: 0.010
  90. Hydrogen peroxide-mediated transcriptional induction of macrophage colony-stimulating factor by TGF-beta1. J Immunol. 1997 Sep 01; 159(5):2418-23.
    View in: PubMed
    Score: 0.010
  91. Modulation of bradykinin receptor ligand binding affinity and its coupled G-proteins by nitric oxide. J Biol Chem. 1997 Aug 01; 272(31):19601-8.
    View in: PubMed
    Score: 0.010
  92. Role of ROCK2 in CD4+ cells in allergic airways responses in mice. Clin Exp Allergy. 2017 Feb; 47(2):224-235.
    View in: PubMed
    Score: 0.009
  93. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017 01; 48(1):187-194.
    View in: PubMed
    Score: 0.009
  94. MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation. Vascul Pharmacol. 2016 09; 84:67-73.
    View in: PubMed
    Score: 0.009
  95. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest. 1995 Dec; 96(6):2661-6.
    View in: PubMed
    Score: 0.009
  96. ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice. Am J Physiol Lung Cell Mol Physiol. 2015 Oct 01; 309(7):L736-46.
    View in: PubMed
    Score: 0.008
  97. MnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1. Vascul Pharmacol. 2015 Sep; 72:163-71.
    View in: PubMed
    Score: 0.008
  98. Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest. 1995 Apr; 95(4):1457-63.
    View in: PubMed
    Score: 0.008
  99. Abrogation of airway hyperresponsiveness but not inflammation by rho kinase insufficiency. Clin Exp Allergy. 2015 Feb; 45(2):457-70.
    View in: PubMed
    Score: 0.008
  100. Critical role of exogenous nitric oxide in ROCK activity in vascular smooth muscle cells. PLoS One. 2014; 9(10):e109017.
    View in: PubMed
    Score: 0.008
  101. The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor. J Clin Invest. 1993 Nov; 92(5):2168-72.
    View in: PubMed
    Score: 0.007
  102. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol. 2013 Jul; 33(7):1591-600.
    View in: PubMed
    Score: 0.007
  103. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation. J Sex Med. 2013 Jun; 10(6):1502-15.
    View in: PubMed
    Score: 0.007
  104. ROCK1 & 2 perform overlapping and unique roles in angiogenesis and angiosarcoma tumor progression. Curr Mol Med. 2013 Jan; 13(1):205-19.
    View in: PubMed
    Score: 0.007
  105. Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion. PLoS One. 2012; 7(11):e47842.
    View in: PubMed
    Score: 0.007
  106. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis. Circulation. 2012 Oct 30; 126(18):2236-47.
    View in: PubMed
    Score: 0.007
  107. Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor. Circ Res. 1992 May; 70(5):1018-26.
    View in: PubMed
    Score: 0.007
  108. ROCK inhibition prevents fetal serum-induced alteration in structure and function of organ-cultured mesenteric artery. J Muscle Res Cell Motil. 2011 Sep; 32(2):65-76.
    View in: PubMed
    Score: 0.006
  109. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis. Hum Mol Genet. 2011 Jun 15; 20(12):2344-55.
    View in: PubMed
    Score: 0.006
  110. Pitavastatin-induced angiogenesis and arteriogenesis is mediated by Notch1 in a murine hindlimb ischemia model without induction of VEGF. Lab Invest. 2011 May; 91(5):691-703.
    View in: PubMed
    Score: 0.006
  111. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol. 2011 Jan; 69(1):119-29.
    View in: PubMed
    Score: 0.006
  112. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest. 2010 Sep; 120(9):3280-95.
    View in: PubMed
    Score: 0.006
  113. Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today. 2010 Aug; 15(15-16):622-9.
    View in: PubMed
    Score: 0.006
  114. RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J. 2010 Sep; 24(9):3186-95.
    View in: PubMed
    Score: 0.006
  115. Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice. Circulation. 2010 Mar 09; 121(9):1104-12.
    View in: PubMed
    Score: 0.006
  116. gamma-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2009 May 29; 383(2):216-21.
    View in: PubMed
    Score: 0.005
  117. Identification of ROCK1 as an upstream activator of the JIP-3 to JNK signaling axis in response to UVB damage. Sci Signal. 2008 Nov 25; 1(47):ra14.
    View in: PubMed
    Score: 0.005
  118. Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor. Can J Physiol Pharmacol. 2008 Sep; 86(9):633-42.
    View in: PubMed
    Score: 0.005
  119. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res. 2008 Sep 12; 103(6):591-7.
    View in: PubMed
    Score: 0.005
  120. Deficiency of ROCK1 in bone marrow-derived cells protects against atherosclerosis in LDLR-/- mice. FASEB J. 2008 Oct; 22(10):3561-70.
    View in: PubMed
    Score: 0.005
  121. Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci U S A. 2008 Mar 25; 105(12):4856-61.
    View in: PubMed
    Score: 0.005
  122. Distribution of sphingosine kinase activity and mRNA in rodent brain. J Neurochem. 2007 Oct; 103(2):509-17.
    View in: PubMed
    Score: 0.005
  123. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. J Cereb Blood Flow Metab. 2007 May; 27(5):998-1009.
    View in: PubMed
    Score: 0.005
  124. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4. Am J Physiol Heart Circ Physiol. 2006 May; 290(5):H1997-2006.
    View in: PubMed
    Score: 0.004
  125. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochem Pharmacol. 2006 Mar 14; 71(6):806-17.
    View in: PubMed
    Score: 0.004
  126. Role of angiotensin II receptor subtypes in porcine basilar artery: functional, radioligand binding, and cell culture studies. Life Sci. 2006 Jan 25; 78(9):943-9.
    View in: PubMed
    Score: 0.004
  127. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005 Jun; 25(6):722-9.
    View in: PubMed
    Score: 0.004
  128. Targeting eNOS for stroke protection. Trends Neurosci. 2004 May; 27(5):283-9.
    View in: PubMed
    Score: 0.004
  129. Simvastatin preserves cardiac function in genetically determined cardiomyopathy. J Cardiovasc Pharmacol. 2004 Mar; 43(3):454-61.
    View in: PubMed
    Score: 0.004
  130. Preservation of NO production by statins in the treatment of heart failure. Cardiovasc Res. 2003 Nov 01; 60(2):250-8.
    View in: PubMed
    Score: 0.004
  131. Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol. 2003 Mar; 41(3):474-80.
    View in: PubMed
    Score: 0.004
  132. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest. 2002 Dec; 110(11):1729-38.
    View in: PubMed
    Score: 0.003
  133. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci U S A. 2002 Dec 10; 99(25):16197-202.
    View in: PubMed
    Score: 0.003
  134. Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2003 Jan; 284(1):H133-40.
    View in: PubMed
    Score: 0.003
  135. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001 Apr; 32(4):980-6.
    View in: PubMed
    Score: 0.003
  136. Regulation of myogenic terminal differentiation by the hairy-related transcription factor CHF2. J Biol Chem. 2001 May 25; 276(21):18591-6.
    View in: PubMed
    Score: 0.003
  137. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation. 2000 Dec 19; 102(25):3104-10.
    View in: PubMed
    Score: 0.003
  138. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res. 2000 Jul 07; 87(1):19-25.
    View in: PubMed
    Score: 0.003
  139. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest. 2000 Jul; 106(1):15-24.
    View in: PubMed
    Score: 0.003
  140. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J Cereb Blood Flow Metab. 2000 Apr; 20(4):709-17.
    View in: PubMed
    Score: 0.003
  141. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1808-12.
    View in: PubMed
    Score: 0.003
  142. [Regulation of endothelial NO production by Rho GTPase]. Med Klin (Munich). 1999 Apr 15; 94(4):211-8.
    View in: PubMed
    Score: 0.003
  143. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol. 1998 Jun; 63(6):732-9.
    View in: PubMed
    Score: 0.003
  144. [New findings on the action of HMG-CoA-reductase inhibitors]. Dtsch Med Wochenschr. 1997 Oct 10; 122(41):1255-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.